Stock AXSM AXSOME THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications Axsome Therapeutics, Inc.

Equities

AXSM

US05464T1043

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
71.71 USD +0.27% Intraday chart for Axsome Therapeutics, Inc. +5.61% -9.90%
Apr. 02 Axsome Therapeutics Insider Sold Shares Worth $1,904,942, According to a Recent SEC Filing MT
Apr. 01 Axsome Therapeutics, Inc. Initiates Engage Phase 3 Trial of Solriamfetol for the Treatment of Binge Eating Disorder CI

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. AXSM Stock
  4. News Axsome Therapeutics, Inc.
  5. Official Publications